New Zealand greenlights MDMA-assisted therapy for severe trauma
New Zealand's medicines regulator has approved the use of pharmaceutical-grade MDMA for treating severe post-traumatic stress disorder, making it the second country to do so after Australia. The therapy will be combined with psychotherapy and conducted in controlled clinical settings. Deputy Prime Minister David Seymour said the decision reflects a commitment to innovative treatments.
This summary is AI-generated and original to Mobble; the linked article is the authoritative source.
Original headline: “New Zealand drugs regulator approves use of MDMA to treat severe PTSD.” Browse more stories.